Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors.

[1]  A. Carlsson,et al.  Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors. , 1994, European journal of pharmacology.

[2]  K. Schittkowski.  Parameter estimation in systems of nonlinear equations , 1994 .

[3]  J. Slightom,et al.  D4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells. , 1994, The Journal of biological chemistry.

[4]  M. E. Lajiness,et al.  Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors. , 1994, Molecular pharmacology.

[5]  D2 dopamine receptor stimulation of mitogenesis in transfected Chinese hamster ovary cells: relationship to dopamine stimulation of tyrosine phosphorylations. , 1993, The Journal of pharmacology and experimental therapeutics.

[6]  M. Martres,et al.  Dopamine D3 receptor: basic and clinical aspects. , 1993, Clinical neuropharmacology.

[7]  D. Grandy,et al.  Molecular diversity of the dopamine receptors. , 1993, Annual review of pharmacology and toxicology.

[8]  K. Neve,et al.  Dopamine D2 receptor stimulation of Na+/H+ exchange assessed by quantification of extracellular acidification. , 1992, The Journal of biological chemistry.

[9]  M. Martres,et al.  Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[10]  G. Schingnitz,et al.  Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist. , 1992, European journal of pharmacology.

[11]  J. W. Parce,et al.  Biosensors based on the energy metabolism of living cells: the physical chemistry and cell biology of extracellular acidification. , 1992, Biosensors & bioelectronics.

[12]  Philip Seeman,et al.  Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine , 1991, Nature.

[13]  Bruno Giros,et al.  Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics , 1990, Nature.

[14]  G. F. Hess,et al.  A second molecular form of D2 dopamine receptor in rat and bovine caudate nucleus , 1990, Nature.

[15]  B. Sommer,et al.  The dopamine D2 receptor: two molecular forms generated by alternative splicing. , 1989, The EMBO journal.

[16]  C. Schneider,et al.  Dopamine autoreceptor agonists: resolution and pharmacological activity of 2,6-diaminotetrahydrobenzothiazole and an aminothiazole analogue of apomorphine. , 1987, Journal of medicinal chemistry.

[17]  Radioimmunological determination of fenoterol. Part I: Theoretical fundamentals. , 1985 .

[18]  D. Sibley,et al.  Dopaminergic inhibition of adenylate cyclase correlates with high affinity agonist binding to anterior pituitary D2 dopamine receptors , 1984, Molecular and Cellular Endocrinology.

[19]  R. Lefkowitz,et al.  A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.

[20]  I. Pastan,et al.  Isolation of multiple classes of mutants of CHO cells resistant to cyclic AMP , 1980, Somatic cell genetics.

[21]  R. Lefkowitz,et al.  A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data. , 1980, Molecular pharmacology.